Sulfonylurea Agents Exhibit Peroxisome Proliferator-activated Receptor γ Agonistic Activity*
暂无分享,去创建一个
M. Matsuda | M. Makishima | I. Shimomura | S. Fukuen | M. Iwaki | A. Yasui
[1] M. Lazar,et al. Peroxisome proliferator-activated receptor γ in diabetes and metabolism , 2004 .
[2] Mitchell A. Avery,et al. Identification of Telmisartan as a Unique Angiotensin II: Receptor Antagonist With Selective PPARγ–Modulating Activity , 2004, Hypertension.
[3] M. Matsuda,et al. Induction of Intestinal ATP-binding Cassette Transporters by a Phytosterol-derived Liver X Receptor Agonist* , 2003, Journal of Biological Chemistry.
[4] M. Matsuda,et al. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. , 2003, Diabetes.
[5] Toshio Hayashi,et al. Plasma adiponectin plays an important role in improving insulin resistance with glimepiride in elderly type 2 diabetic subjects. , 2003, Diabetes care.
[6] J. C. Hinshaw,et al. Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARγ agonist , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[7] R. A. Norman,et al. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. , 2002, Diabetes.
[8] M. Kasuga,et al. Role of peroxisome proliferator-activated receptor-gamma in maintenance of the characteristics of mature 3T3-L1 adipocytes. , 2002, Diabetes.
[9] Yang Li,et al. T0070907, a Selective Ligand for Peroxisome Proliferator-activated Receptor γ, Functions as an Antagonist of Biochemical and Cellular Activities* , 2002, The Journal of Biological Chemistry.
[10] M. Matsuda,et al. Small Heterodimer Partner, an Orphan Nuclear Receptor, Augments Peroxisome Proliferator-activated Receptor γ Transactivation* , 2002, The Journal of Biological Chemistry.
[11] M. Matsuda,et al. Enhancement of the Aquaporin Adipose Gene Expression by a Peroxisome Proliferator-activated Receptor γ* , 2001, The Journal of Biological Chemistry.
[12] J. Auwerx,et al. A unique PPARgamma ligand with potent insulin-sensitizing yet weak adipogenic activity. , 2001, Molecular cell.
[13] M. Matsuda,et al. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. , 2001, Diabetes.
[14] K. Griffin,et al. Identification of Peroxisome Proliferator-responsive Human Genes by Elevated Expression of the Peroxisome Proliferator-activated Receptor α in HepG2 Cells* , 2001, The Journal of Biological Chemistry.
[15] S. Kliewer,et al. A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[16] L. Freedman,et al. Discrete Roles for Peroxisome Proliferator-Activated Receptor γ and Retinoid X Receptor in Recruiting Nuclear Receptor Coactivators , 2000, Molecular and Cellular Biology.
[17] T. A. Kerr,et al. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. , 2000, Molecular cell.
[18] J. Olefsky. Treatment of insulin resistance with peroxisome proliferator–activated receptor γ agonists , 2000 .
[19] D. Betteridge,et al. What is oxidative stress? , 2000, Metabolism: clinical and experimental.
[20] B. Spiegelman,et al. A Synthetic Antagonist for the Peroxisome Proliferator-activated Receptor γ Inhibits Adipocyte Differentiation* , 2000, The Journal of Biological Chemistry.
[21] C. Glass,et al. The coregulator exchange in transcriptional functions of nuclear receptors. , 2000, Genes & development.
[22] M. Makishima,et al. Identification of a nuclear receptor for bile acids. , 1999, Science.
[23] T. Willson,et al. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ , 1998, Nature.
[24] R. Evans,et al. Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ , 1998, Cell.
[25] B. Spiegelman. PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. , 1998, Diabetes.
[26] M. Rao,et al. Isolation and Characterization of PBP, a Protein That Interacts with Peroxisome Proliferator-activated Receptor* , 1997, The Journal of Biological Chemistry.
[27] J. Lehmann,et al. Peroxisome Proliferator-activated Receptors α and γ Are Activated by Indomethacin and Other Non-steroidal Anti-inflammatory Drugs* , 1997, The Journal of Biological Chemistry.
[28] D. Mangelsdorf,et al. Unique requirements for retinoid-dependent transcriptional activation by the orphan receptor LXR. , 1997, Genes & development.
[29] M. Lazar,et al. Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[30] J. Lehmann,et al. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation , 1995, Cell.
[31] B. Spiegelman,et al. 15-Deoxy-Δ 12,14-Prostaglandin J 2 is a ligand for the adipocyte determination factor PPARγ , 1995, Cell.
[32] J. Lehmann,et al. An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ) (*) , 1995, The Journal of Biological Chemistry.
[33] B. Spiegelman,et al. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor , 1994, Cell.
[34] K. Umesono,et al. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[35] B. Spiegelman,et al. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. , 1994, Genes & development.
[36] C. Jung,et al. Sulfonylurea potentiates insulin-induced recruitment of glucose transport carrier in rat adipocytes. , 1985, The Journal of biological chemistry.
[37] M. Makishima,et al. Structural determinants for vitamin D receptor response to endocrine and xenobiotic signals. , 2004, Molecular endocrinology.
[38] S. Perrey,et al. Thiazolidinedione- and tumor necrosis factor alpha-induced downregulation of peroxisome proliferator-activated receptor gamma mRNA in differentiated 3T3-L1 adipocytes. , 2001, Metabolism: clinical and experimental.
[39] Z. Wu,et al. PPARgamma induces the insulin-dependent glucose transporter GLUT4 in the absence of C/EBPalpha during the conversion of 3T3 fibroblasts into adipocytes. , 1998, The Journal of clinical investigation.
[40] G. Müller,et al. Extrapancreatic effects of sulfonylureas--a comparison between glimepiride and conventional sulfonylureas. , 1995, Diabetes research and clinical practice.
[41] W. Waldhäusl,et al. DOSE LINEARITY ASSESSMENT OF GLIMEPIRIDE (AMARYL®) TABLETS IN HEALTHY VOLUNTEERS , 1994, Drug metabolism and drug interactions.